Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
noncoml
on May 31, 2024
|
parent
|
context
|
favorite
| on:
Trial results for new lung cancer drug are 'off th...
There are similar drugs(eg osimertinib) for EGFR+ cancers, which are estimated to be 10-33% of NSCLC.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
